Article Versions Notes

Al Malik YM, Al Thubaiti IA, AlAmmari MA, Al Fugham N, Ali EN, Alissa DA, Aljarallah SA, Al-Jedai AH, AlKathiri MA, AlKhawajah MM, et al. Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Disease-Modifying Therapies and Management of Relapses. Clinical and Translational Neuroscience. 2022; 6(4):27. https://doi.org/10.3390/ctn6040027

Al Malik, Yaser M., Ibtisam A. Al Thubaiti, Maha A. AlAmmari, Norah Al Fugham, Eman N. Ali, Dema A. Alissa, Salman A. Aljarallah, Ahmed H. Al-Jedai, Maeed A. AlKathiri, Mona M. AlKhawajah, and et al. 2022. "Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Disease-Modifying Therapies and Management of Relapses" Clinical and Translational Neuroscience 6, no. 4: 27. https://doi.org/10.3390/ctn6040027

Al Malik, Y. M., Al Thubaiti, I. A., AlAmmari, M. A., Al Fugham, N., Ali, E. N., Alissa, D. A., Aljarallah, S. A., Al-Jedai, A. H., AlKathiri, M. A., AlKhawajah, M. M., Almejally, M. A., Al-Mudaiheem, H. Y., Al Otaibi, H. S., AlTowaijri, G. H., Al Yafeai, R. H., Babakkor, M. A., Bohlega, S. A., Bunyan, R. F., Cupler, E. J., ... Al Jumah, M. A. (2022). Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Disease-Modifying Therapies and Management of Relapses. Clinical and Translational Neuroscience, 6(4), 27. https://doi.org/10.3390/ctn6040027